Quick access:

SEQENS inaugurates an innovative HPAPI unit at its Villeneuve-La-Garenne plant, France


The site was inaugurated in the presence of Emmanuel Macron, President of the French Republic and Bruno Lemaire, Minister of the Economy, Finance and Recovery.

MRM Health appoints Dr. Werner Cautreels as Chairman and Dr. Nigel Horscroft as Chief Scientific Officer


Dr. Werner Cautreels, former CEO of Solvay Pharmaceuticals and Selecta Biosciences, has been appointed as Chairman of the Board and Dr. Nigel Horscroft, ex-Curevac and Pfizer, as Chief Scientific Officer. In addition, Dr. Ludo Haazen is joining the R&D organization to support clinical development and medical affairs.

Mérieux Equity Partners and Korys announce the launch of OMX Europe Venture Fund, dedicated to Venture investment within the healthcare and nutrition sectors


The new investment platform in Venture Capital will support innovative companies in the healthcare and nutrition sectors, in Europe and North America.

L'Entreprise des Possibles is Mobilizing Businesses to help the homeless in Lyon


First results and sollicitating sponsorships, partnerships and donations.

Nutragroup is fully mobilized to first guarantee the safety and health of its employees, but also to contribute to supporting and enhancing the Health of the Human Beings against the Covid-19 threat


Nutragroup will keep delivering particular vitamins and immuno-stimulants to their customers (Food Supplement laboratories).

Seqens is fully mobilized to guarantee the safety and health of its employees and also to contribute to supporting the Healthcare systems in the Covid-19 battle


Seqens will keep providing active ingredients and pharmaceutical intermediates such as paracetamol and keep developing antivirals and disinfecting solutions.

CEVA Santé Animale returns to strong double-digit growth in 2019 and reveals plans to double sales by 2025


Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.

Ceva Santé Animale reorganizes its shareholding structure, welcoming new long-term partners alongside existing investors


Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program